Zhitong Finance App News, Jiudian Pharmaceutical (300705.SZ) issued an announcement. The company recently received the “Drug Registration Certificate” for trimebutine maleate tablets issued by the State Drug Administration. Trimebutine maleate tablets are used to treat symptoms such as loss of appetite, nausea, vomiting, belching, bloating, abdominal pain, diarrhea, and constipation caused by irritable bowel syndrome and gastrointestinal motility disorders. It was first approved for listing in France in 1970. Currently, dosage forms such as tablets, capsules, and dry suspensions are sold at home and abroad.

Zhitong Finance App News, Jiudian Pharmaceutical (300705.SZ) issued an announcement. The company recently received the “Drug Registration Certificate” for trimebutine maleate tablets issued by the State Drug Administration. Trimebutine maleate tablets are used to treat symptoms such as loss of appetite, nausea, vomiting, belching, bloating, abdominal pain, diarrhea, and constipation caused by irritable bowel syndrome and gastrointestinal motility disorders. It was first approved for listing in France in 1970. Currently, dosage forms such as tablets, capsules, and dry suspensions are sold at home and abroad.